臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shao y y"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 1-25 of 396 (16 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-09-15T01:09:06Z	Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors	Guo J.-C.; Chia-Chi Lin; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H.
臺大學術典藏	2022-09-14T01:29:27Z	Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan	Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; CHIEN-HUNG CHEN; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group
臺大學術典藏	2022-09-14T01:29:23Z	Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy	Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; CHIEN-HUNG CHEN; Cheng A.-L.
臺大學術典藏	2022-08-19T06:48:44Z	Impact of expanded strong opioid availability on opioid prescription patterns in patients with cancer: A population-wide cohort study in Taiwan	Wu T.-C.; CHIH-HUNG HSU; Sun W.-Z.; Chen H.-M.; Lin C.-P.; Shao Y.-Y.
臺大學術典藏	2022-08-19T06:48:40Z	Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma	Shao Y.-Y.; Kuo H.-Y.; Jeng Y.-M.; Wu Y.-M.; Wang H.-P.; Hsu C.; CHIH-HUNG HSU; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏	2022-08-19T00:21:03Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Cheng A.-L.; Ding Y.-H.; CHIUN HSU; Shao Y.-Y.; Chen P.-J.; Lin Z.-Z.; Shen Y.-C.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:21:02Z	Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin	Cheng A.-L.; Lin C.-H.; Chang K.-J.; Kuo W.-H.; CHIUN HSU; Lee W.-C.; Liau J.-Y.; Huang C.-S.; Lu Y.-S.; Shao Y.-Y.; Kuo K.-T.; Hu F.-C.
臺大學術典藏	2022-08-19T00:21:01Z	Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma	Cheng A.-L.; Hsu C.-H.; Shen Y.-C.; CHIUN HSU; Lin Z.-Z.; Shao Y.-Y.
臺大學術典藏	2022-08-19T00:20:58Z	Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma	Shao Y.-Y.; Lin Z.-Z.; CHIUN HSU; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:57Z	Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy	Yang C.-H.; Hong R.-L.; Hsu C.-H.; Chengb A.-L.; Chang D.-Y.; Hu F.-C.; Shao Y.-Y.; CHIUN HSU; Lin Z.-Z.
臺大學術典藏	2022-08-19T00:20:55Z	Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems	Shen Y.-C.; Hsu C.-H.; Cheng A.-L.; CHIUN HSU; Lin Z.-Z.; Lu L.-C.; Shao Y.-Y.
臺大學術典藏	2022-08-19T00:20:51Z	Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size	Lai M.-S.; Yang J.C.-H.; Cheng A.-L.; Hsu C.-H.; Kuo R.N.-C.; Yeh Y.-C.; Shao Y.-Y.; CHIUN HSU; Shau W.-Y.; Lin Z.-Z.
臺大學術典藏	2022-08-19T00:20:45Z	The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia	Yang J.C.H.; Lai M.-S.; Cheng A.-L.; Cheng W.-F.; CHIUN HSU; Shao Y.-Y.; Yang Y.-Y.; Lai C.-L.; Shau W.-Y.; Kuo R.; Lin Z.-Z.; Kuo H.-Y.
臺大學術典藏	2022-08-19T00:20:43Z	Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression	Ou D.-L.; Cheng A.-L.; Shao Y.-Y.; Feng Z.-R.; Lin L.-I.; Cheng Y.-C.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:40Z	Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy	CHIUN HSU; Wang M.-J.; Cheng A.-L.; Shao Y.-Y.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:20:38Z	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Cheng A.-L.; Hsu C.-H.; Shen Y.-C.; CHIUN HSU; Lin Z.-Z.; Liu T.-H.; Shao Y.-Y.; Lu L.-C.
臺大學術典藏	2022-08-19T00:20:36Z	Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma	Shao Y.-Y.; Liu T.-H.; CHIUN HSU; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:20:30Z	Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma	Hung Y.-P.; Shao Y.-Y.; Lee J.-M.; CHIUN HSU; Hsu C.-H.; Yang M.-H.; Chao Y.
臺大學術典藏	2022-08-19T00:20:28Z	The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma	Hung Y.-P.; CHIUN HSU; Lee J.-M.; Chao Y.; Shao Y.-Y.; Hsu C.-H.; Yang M.-H.
臺大學術典藏	2022-08-19T00:20:28Z	Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma	Sun N.-Y.; CHIUN HSU; Cheng A.-L.; Shao Y.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.-H.; Hsu H.-C.; Lin Z.-Z.
臺大學術典藏	2022-08-19T00:20:27Z	Early changes in dce-mri biomarkers may predict survival outcomes in patients with advanced hepatocellular carcinoma after sorafenib failure: Two prospective phase ii trials	Lin Z.-Z.; Hsu C.-H.; Liang P.-C.; Chen B.-B.; Shao Y.-Y.; CHIUN HSU; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2022-08-19T00:20:27Z	Dynamic contrast-enhanced and intravoxel incoherent motion mri biomarkers are correlated to survival outcome in advanced hepatocellular carcinoma	Lin Z.-Z.; Cheng A.-L.; Shih T.T.-F.; Chen B.-B.; Shao Y.-Y.; Hsu C.-H.; CHIUN HSU; Liang P.-C.
臺大學術典藏	2022-08-19T00:20:26Z	Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy	CHIUN HSU; Shao Y.-Y.; Chen C.-H.; Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.-H.; Lin Z.-Z.; Lu L.-C.; Liu T.-H.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:25Z	Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma	Liang P.-C.; Liu T.-H.; Lu L.-C.; CHIUN HSU; Shao Y.-Y.; Chen B.-B.; Shih T.T.-F.; Shen Y.-C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:23Z	Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma	Shao Y.-Y.; Lin L.-I.; Ling A.; CHIUN HSU; Chen P.-S.; Lee B.-S.; Cheng A.-L.; Ou D.-L.

Showing items 1-25 of 396 (16 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 53291100 Online Users : 964 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library